NCT04389294View on ClinicalTrials.gov

HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists

NACompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

June 16, 2020

Study Completion Date

September 4, 2020

Conditions
COVID
Interventions
DIAGNOSTIC_TEST

SARS-CoV2 serum antibody testing

Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other.

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER

NCT04389294 - HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists | Biotech Hunter | Biotech Hunter